Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
3.45 Up 0.21(6.48%) Jul 31, 4:00PM EDT
Add to Portfolio
Prev Close:3.24
Open:3.24
Bid:3.40 x 2000
Ask:3.62 x 400
1y Target Est:6.00
Beta:0.58
Next Earnings Date:13-Aug-15OGXI Earnings announcement
Day's Range:3.16 - 3.54
52wk Range:1.74 - 4.10
Volume:1,239,269
Avg Vol (3m):686,570
Market Cap:81.98M
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIUp 6.48%81.98M
BMYUp 1.83%109.45B
CELGDown 0.48%104.10B
PFEUp 0.92%222.05B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.97
Quarterly EPS Est (Jun-15) :0.34
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback